PH21842A - Crystalline sodium salt of d-6-o(-(2-oxo-3-furfurylidene-amino-imidazolidin-1-yl)carbonyl-amino)-2-thienylacetamido-penicillanic acid - Google Patents

Crystalline sodium salt of d-6-o(-(2-oxo-3-furfurylidene-amino-imidazolidin-1-yl)carbonyl-amino)-2-thienylacetamido-penicillanic acid

Info

Publication number
PH21842A
PH21842A PH32687A PH32687A PH21842A PH 21842 A PH21842 A PH 21842A PH 32687 A PH32687 A PH 32687A PH 32687 A PH32687 A PH 32687A PH 21842 A PH21842 A PH 21842A
Authority
PH
Philippines
Prior art keywords
amino
thienylacetamido
imidazolidin
oxo
sodium salt
Prior art date
Application number
PH32687A
Inventor
Hans-Bodo Konig
Karl Georg Metzger
Wilfried Schrock
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of PH21842A publication Critical patent/PH21842A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/44Compounds with an amino radical acylated by carboxylic acids, attached in position 6
    • C07D499/48Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical
    • C07D499/58Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical
    • C07D499/64Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical by nitrogen atoms
    • C07D499/70Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical by nitrogen atoms with hetero rings as additional substituents on the carbon chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

1. Sodium salt of D-6-{alpha-[(2-oxo-3- furfurylideneamino-imidazolidin-1-yl)-carbonylamino]-2- thienylacetamido}-penicillanic acid of the formula (I) see diagramm : EP0176716,P8,F2 in pure crystalline form, characterized by the following NMR signals : delta = 9.36 (1H), 9.23 (1H), 7.8 (2H), 7.5 (1H), 7.25 (1H), 7.05 (1H), 6.89 (1H), 6.62 (1H), 6.2 (1H), 5.74 (1H), 5.56 (1H), 4.35 (1H), 3.92 (4H), 1.6 (3H) and 1,5 ppm (3H) (in DMF-d7 ).
PH32687A 1984-08-25 1985-08-23 Crystalline sodium salt of d-6-o(-(2-oxo-3-furfurylidene-amino-imidazolidin-1-yl)carbonyl-amino)-2-thienylacetamido-penicillanic acid PH21842A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843431273 DE3431273A1 (en) 1984-08-25 1984-08-25 CRYSTALLINE SODIUM SALT OF THE D-6 - ((ALPHA) - (2-OXO-3-FURFURYL-IDEN-AMINO-IMIDAZOLIDIN-1-YL) -CARBONYLAMINO) -THIENYL-2-ACETAMIDO) -PENICILLANIC ACID, METHODS OF PROCESSING IN MEDICINAL PRODUCTS
CN85106479A CN85106479B (en) 1984-08-25 1985-08-29 Crystalline D-6 {alpha-[(2-aldo-3-furfurylidene-amino-1-imidazolidinyl) carbonyl amino]-2 thienylacetamido}-penicillanic acid salt with sodium, process thereof and use as medicine

Publications (1)

Publication Number Publication Date
PH21842A true PH21842A (en) 1988-03-17

Family

ID=25741999

Family Applications (1)

Application Number Title Priority Date Filing Date
PH32687A PH21842A (en) 1984-08-25 1985-08-23 Crystalline sodium salt of d-6-o(-(2-oxo-3-furfurylidene-amino-imidazolidin-1-yl)carbonyl-amino)-2-thienylacetamido-penicillanic acid

Country Status (18)

Country Link
EP (1) EP0176716B1 (en)
JP (1) JPS6157589A (en)
KR (1) KR860001818A (en)
CN (1) CN85106479B (en)
AT (1) ATE34576T1 (en)
AU (1) AU559040B2 (en)
DE (2) DE3431273A1 (en)
DK (1) DK385085A (en)
ES (1) ES8609340A1 (en)
FI (1) FI853211L (en)
GR (1) GR852047B (en)
HU (1) HU194893B (en)
IL (1) IL76164A0 (en)
NO (1) NO853188L (en)
NZ (1) NZ213198A (en)
PH (1) PH21842A (en)
PT (1) PT81014B (en)
ZA (1) ZA856413B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW347383B (en) * 1995-10-26 1998-12-11 Biochemie Gmbh A process for the production of a crystalline sodium salt of amoxicillin in ethanol as solvent
US9844374B2 (en) 2014-12-18 2017-12-19 Ethicon Llc Surgical instrument systems comprising an articulatable end effector and means for adjusting the firing stroke of a firing member

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL85039B1 (en) * 1972-02-17 1977-02-26 Tarchomińskie Zakłady Farmaceutyczne Method for the preparation of sodium salt of α-ftminobenzylopeiiicylmy
PL87153B1 (en) * 1973-07-13 1976-12-15 Tarchomińskie Zakłady Farmaceutyczne Method of obtaining crystalline penicillin disodium salt of α-carboxybenzyl
DE2732323A1 (en) * 1977-07-16 1979-01-25 Bayer Ag BETA-LACTAM COMPOUNDS, THE PROCESS FOR THEIR PRODUCTION AND THEIR USE
DE2732283A1 (en) * 1977-07-16 1979-01-25 Bayer Ag BETA-LACTAM COMPOUNDS
JPS5940727A (en) * 1982-07-28 1984-03-06 Fujitsu Ltd Automatic equalization system

Also Published As

Publication number Publication date
EP0176716A1 (en) 1986-04-09
PT81014A (en) 1985-09-01
AU559040B2 (en) 1987-02-19
EP0176716B1 (en) 1988-05-25
ES8609340A1 (en) 1986-07-16
FI853211A0 (en) 1985-08-21
JPS6157589A (en) 1986-03-24
FI853211L (en) 1986-02-26
ZA856413B (en) 1986-04-30
ATE34576T1 (en) 1988-06-15
DE3431273A1 (en) 1986-03-06
KR860001818A (en) 1986-03-22
PT81014B (en) 1987-12-30
DK385085D0 (en) 1985-08-23
CN85106479A (en) 1987-03-18
DK385085A (en) 1986-02-26
ES546379A0 (en) 1986-07-16
HU194893B (en) 1988-03-28
AU4657785A (en) 1986-02-27
CN85106479B (en) 1988-07-27
NZ213198A (en) 1989-02-24
IL76164A0 (en) 1985-12-31
DE3562918D1 (en) 1988-06-30
HUT38354A (en) 1986-05-28
NO853188L (en) 1986-02-26
GR852047B (en) 1985-12-20

Similar Documents

Publication Publication Date Title
ES8505190A1 (en) Stabilized aqueous formulations of sulfonylureas.
DE3777611D1 (en) SOLUTION CONTAINING LYSOCYME HYDROCHLORIDE AND DIKALIUM GLYCYRRHIZINATE.
ES8703438A1 (en) Thia (oxa) diazole derivatives
DE3573601D1 (en) Sulfate of 5,6,7,8-tetrahydro-l-erythro-biopterin and process for preparing the same
PH21842A (en) Crystalline sodium salt of d-6-o(-(2-oxo-3-furfurylidene-amino-imidazolidin-1-yl)carbonyl-amino)-2-thienylacetamido-penicillanic acid
ES8401930A1 (en) Nitrobenzoic acid amide derivatives.
IL51272A (en) Production of 3,3-dimethyl-2-oxo-butyric acid salts
TR21438A (en) A WATERPROOF CONCENTRATE CONTAINING A PESTICID AND AN AROMATIC SULPHONIC ACID OR SALT
ES8700650A1 (en) 7-(Aryloxy)-2-naphthoxyalkanecarboxylic acid derivatives, processes for the preparation of these compounds, as well as agents having herbicidal activity containing these compounds.
JPS5325536A (en) Production of paraa isobutyl hydroatropic acid derivatives
FR2479813B1 (en)
ATE92073T1 (en) PHOSPHORIC DIESTERS AND SALTS THEREOF.
UA6327A1 (en) Process for preparation of haloidpyridine
DE3163803D1 (en) 2-methyl-5-thiazole-methylamine and carboxamide derivatives
ATE35981T1 (en) UREA ACRYLIC DERIVATIVES.
GB1512863A (en) Preparation of salts of oxonals
ES446874A1 (en) Novel chromone derivatives
SU604494A3 (en) Method of preparing 2,5-dimethyl-thieno-(3,2-f) morphane
GB1491434A (en) 3-aminomethyl-4-homoisotwistane and acid addition salts thereof
DE3461189D1 (en) New 3-alkylthio-2-o-carbamoyl-propane-1.2-diol-1-o-phosphocholines, and processes for their preparation
EP0333304A3 (en) Herbicidal sulfonamides
RO85437B1 (en) Process for manufacturing polyethoxylated soap
JPS5350192A (en) Novel cephalosporin derivatives
JPS53124277A (en) 1-substed-(1,2-diphenylpropyl)piperazines